Paul A Volberding
Overview
Explore the profile of Paul A Volberding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
3187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Volberding P
Top Antivir Med
. 2015 Jan;
22(5):694-7.
PMID: 25612178
The 20th International AIDS Conference held in Melbourne, Australia, from July 20 through July 25, 2014, provided much new data on nucleoside analogue reverse transcriptase inhibitor-sparing antiretroviral therapy, potential consequences...
12.
Tucker J, Volberding P, Margolis D, Rennie S, Barre-Sinoussi F
J Acquir Immune Defic Syndr
. 2014 Oct;
67(3):e110-1.
PMID: 25314254
No abstract available.
13.
Gunthard H, Aberg J, Eron J, Hoy J, Telenti A, Benson C, et al.
JAMA
. 2014 Jul;
312(4):410-25.
PMID: 25038359
Importance: New data and antiretroviral regimens expand treatment choices in resource-rich settings and warrant an update of recommendations to treat adults infected with human immunodeficiency virus (HIV). Objective: To provide...
14.
Volberding P
J Acquir Immune Defic Syndr
. 2013 Jun;
63(4):417.
PMID: 23722609
No abstract available.
15.
Thompson M, Aberg J, Hoy J, Telenti A, Benson C, Cahn P, et al.
JAMA
. 2012 Jul;
308(4):387-402.
PMID: 22820792
Context: New trial data and drug regimens that have become available in the last 2 years warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected...
16.
Tabas J, Boscardin C, Jacobsen D, Steinman M, Volberding P, Baron R
Arch Intern Med
. 2011 May;
171(9):840-6.
PMID: 21555662
Background: Pharmaceutical and medical device company funding supports up to 60% of accredited continuing medical education (CME) costs in the United States. Some have proposed measures to limit the size,...
17.
Dykes C, Mukherjee A, Bosch R, Connick E, Volberding P, Demeter L
J Acquir Immune Defic Syndr
. 2010 Aug;
55(1):132-4.
PMID: 20733405
No abstract available.
18.
Thompson M, Aberg J, Cahn P, Montaner J, Rizzardini G, Telenti A, et al.
JAMA
. 2010 Jul;
304(3):321-33.
PMID: 20639566
Context: Recent data regarding the consequences of untreated human immunodeficiency virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and antiretroviral-experienced patients warrant an update of the International...
19.
Volberding P, Deeks S
Lancet
. 2010 Jul;
376(9734):49-62.
PMID: 20609987
Antiretroviral therapy of HIV infection has changed a uniformly fatal into a potentially chronic disease. There are now 17 drugs in common use for HIV treatment. Patients who can access...
20.
Choi A, Li Y, Parikh C, Volberding P, Shlipak M
Kidney Int
. 2010 Jun;
78(5):478-85.
PMID: 20520594
To evaluate the long-term consequences of acute kidney injury (AKI) in human immunodeficiency virus (HIV)-infected persons, we studied 17,325 patients in a national HIV registry during their first hospitalization. We...